Prevalence Of Androgen Receptor Positivity In Triple Negative Breast Cancer

Journal Title: Journal of Integrative Oncology - Year 2018, Vol 7, Issue 1

Abstract

A unique subgroup of breast cancer, the Triple negative Breast carcinoma (TNBC) is on the rising trend. TNBC occurrence is around 15-20% of all breast cancers. Therefore this makes it an ideal target for therapeutic exploitation. TNBC is defined by the absence of a target, therefore, there is absence of a tailored targeted therapy, leaving its management depend on conventional cytotoxic regimens. The presence of AR in ER negative cases is 30%, in TNBC the AR positivity is <20% (some studies have even accounted that the overall AR positivity in Breast cancer is 60-70%). This group of patients poses a major challenge to the physicians and patientsThe total breast cancer patients between the periods of October 2014 to February 2014 were 734 cases, 142 cases were triple negative breast cancer cases as demonstrated by the Immunohistochemistry. Androgen receptor was considered positive if >10% of cells showed positivity in Immunohistochemistry. Androgen receptor is Negative amongst a majority of 88% of patients with 12% remaining AR Positive off which 8% is High, 3 Medium and 1 Low Positive. The p value is 0.000 which is <0.05 hence the value is significant. The percentage of AR positivity in TNBC in this study concurs with the literature findings. This explains the importance of the same in TNBC as it seems to be an important avenue for therapeutic targeting because, this group of patients do not have much options for treatment. Further studies, with the use of androgen receptor blockade through drugs like Bicalutamide/Enzalutamide/Abireterone in AR positive TNBC could be studied to know the survival improvement.

Authors and Affiliations

Martin P Jovita M, Kalaichelvi Kannan, Kumar S Suresh

Keywords

Related Articles

Role of Specific Cancer Treatments in Pain Management

Cancer is characterized by tissue invasion leading to destruction, inflammation, irritation, obstructions and compressions. All these causes of pain may be present in varying degrees in all stages. The pain management th...

Development of Comprehensive Yoga Program for Cervical Carcinoma

Background: Prior research reveal the benefits of yoga in managing fatigue, stress and psychosocial outcomes in cervical carcinoma; however, a definite structured yoga program is unavailable. In this study an effort is m...

The Chernobyl and It’s Long Term Consequence: Clinical Cases of Leukemia

The Chernobyl accident that occurred 30 years ago was one of the worst nuclear disasters ever. Although it’s effects have been the subject of several articles, the role of its repercussions in the etiology of hematologic...

Analysis of Set-up Parameters in Head and Neck Patients at the Charlotte Maxeke Johannesburg Academic Hospital (A Review of Current Clinical Practice)

This study aimed to collect and analyze the recorded daily setup parameters of the bed as incidentally captured on an integrated record and verify system. This was done on some radical head and neck patients treated from...

Ovarian Function Suppression: Is it the Right Time to Jump the Gun?

Ovarian function suppression (OFS) an old endocrine therapy has been tested in premenopausal women with early breast cancer (EBC) but not widely accepted in modern practice. The question is re-addressed in recent big tri...

Download PDF file
  • EP ID EP348918
  • DOI 10.4172/2329-6771.1000205
  • Views 54
  • Downloads 0

How To Cite

Martin P Jovita M, Kalaichelvi Kannan, Kumar S Suresh (2018). Prevalence Of Androgen Receptor Positivity In Triple Negative Breast Cancer. Journal of Integrative Oncology, 7(1), 1-6. https://europub.co.uk/articles/-A-348918